You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Trametinib

Showing 1 - 25 of 253
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Arteriovenous Malformations Trial (Trametinib tablet)

Not yet recruiting
  • Arteriovenous Malformations
  • Trametinib tablet
  • (no location specified)
Oct 17, 2023

Cholangiocarcinoma Trial (GNS561 + Trametinib)

Not yet recruiting
  • Cholangiocarcinoma
  • GNS561 + Trametinib
  • (no location specified)
May 22, 2023

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Cancer Trial (Dabrafenib, Trametinib)

Not yet recruiting
  • Cancer
  • (no location specified)
May 25, 2023

Aspirin in Combination With Trametinib and Dabrafenib

Not yet recruiting
  • NSCLC
  • +4 more
  • Combind asprin with Trametinib and Dabrafenib
  • (no location specified)
Aug 4, 2023

Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)

Not yet recruiting
  • Leukemia, Juvenile Myelomonocytic
  • +4 more
  • Trametinib
  • +3 more
  • (no location specified)
May 4, 2023

NSCLC Trial in Davis, San Francisco (Ceritinib, Trametinib)

Terminated
  • Non-small Cell Lung Cancer
  • Davis, California
  • +1 more
Dec 22, 2022

Healthcare Resource Utilization and Costs in Metastatic Melanoma

Terminated
  • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Apr 27, 2023

    Metastatic Malignant Tumor in the Brain Trial in Columbus (other, procedure, drug, radiation)

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Brain
    • Laboratory Biomarker Analysis
    • +4 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Oct 15, 2022

    Melanoma Trial in Norway (BGB324+pembrolizumab, BGB324+dabrafenib and trametinib, pembrolizumab)

    Active, not recruiting
    • Melanoma
    • Bergen, Norway
    • +4 more
    Aug 24, 2022

    Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive

    Not yet recruiting
    • Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
    • Non-investigational
    • (no location specified)
    May 11, 2023

    Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City

    Recruiting
    • Metastatic Pancreatic Carcinoma
    • +6 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute/University of Utah
    Oct 31, 2022

    BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,

    Recruiting
    • BRAF NP_004324.2:p.V600E
    • +2 more
    • Duarte, California
    • +1 more
    Jan 19, 2023

    Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Singapore (Trametinib, Ruxolitinib)

    Recruiting
    • Colorectal Cancer
    • Pancreatic Adenocarcinoma
    • Singapore, Singapore
      National Cancer Centre
    Jun 10, 2022

    Cancer, BRAF V600 Mutation, Melanoma Trial (XP-102, Trametinib)

    Not yet recruiting
    • Cancer
    • +5 more
    • (no location specified)
    Aug 18, 2022

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Trametinib Dimethyl Sulfoxide
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Aug 13, 2022

    Metastatic Melanoma, BRAF Gene Mutation Trial in Lexington (Nilotinib 100mg, Nilotinib 200mg, Nilotinib 300mg)

    Recruiting
    • Metastatic Melanoma
    • BRAF Gene Mutation
    • Nilotinib 100mg
    • +5 more
    • Lexington, Kentucky
      Markey Cancer Center
    Jul 22, 2022

    Associated Factors, and Clinical Outcomes of Prescribing

    Completed
    • BRAF v600 Mutated Metastatic Melanoma
      • East Hanover, New Jersey
        Novartis Pharmaceuticals
      Mar 28, 2023

      Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer Trial in San Francisco (Capmatinib, Trametinib)

      Recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • Stage IV Lung Cancer
      • San Francisco, California
        University of California San Francisco
      Aug 15, 2022

      Metastatic Colorectal Cancer Trial in Boston (Dabrafenib, Trametinib, PDR001)

      Recruiting
      • Metastatic Colorectal Cancer
      • Boston, Massachusetts
      • +1 more
      Jun 24, 2022

      Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,

      Not yet recruiting
      • Advanced Uveal Melanoma
      • +2 more
      • BRD4 Inhibitor PLX2853
      • +4 more
      • (no location specified)
      Jan 9, 2023

      EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

      Recruiting
      • EGFR NP_005219.2:p.S492R
      • +7 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

      Active, not recruiting
      • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 9, 2022

      Histiocytosis Trial in Warsaw (Trametinib)

      Recruiting
      • Histiocytosis
      • Trametinib
      • Warsaw, Mazovian, Poland
        Mother and Child Institute
      Aug 2, 2022

      BRAF V600-mutated Lung Carcinoma Treated With Combination of

      Completed
      • Non Small Cell Lung Cancer
      • BRAF V600 Mutation
        • Créteil, France
        • +1 more
        Jun 29, 2022